Foster Dykema Cabot & Co’s Viatris VTRS Stock Holding History

Foster Dykema Cabot & Co’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-103	Closed	-$1K	–	392
2023 Q2	$1K	Buy	+103	New	+$984	﹤0.01%	380

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Foster Dykema Cabot & Co's VTRS Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Viatris (VTRS) in Q3 2023, closing a stake of 103 shares — an estimated $1K sold.

Foster Dykema Cabot & Co first reported a position in VTRS in Q2 2023 and held it in 1 quarter. The position peaked at $1K in Q2 2023. 960 funds tracked by Wall St. Rank hold VTRS as of Q3 2023.

Foster Dykema Cabot & Co reported no remaining Viatris position as of Q3 2023 after selling out during the quarter.
Foster Dykema Cabot & Co sold 103 Viatris shares in Q3 2023, an estimated $1K.
Foster Dykema Cabot & Co first reported a position in Viatris in Q2 2023 and held it in 1 quarter.
Foster Dykema Cabot & Co's Viatris position peaked at $1K in Q2 2023.
960 funds tracked by Wall St. Rank held Viatris as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.